The purpose of this agreement is for the development of medical countermeasures for protection from pneumonic plague.
Other Transaction IDV Awarded Last action
- Contract number
- W911SR2590003
- Awardee
-
Dynavax Technologies Corporation UEI JA7GSG397PL1
- Awarding agency
-
ACC Aberdeen Proving Ground
Army Contracting Command, Department of Defense
- Task orders
- 0
Award facts
- Last date to order
- Not on record
- IDV ceiling
- $51,310,986.00
- Contracting staff
- Funding agency
- Joint PEO Chemical and Biological Defense Acquisition Support Center, Department of Defense
- NAICS code
- Not on record
- Competition
- Competed Broad Agency Announcement
- Pricing
- Other
Award details come from SAM.gov/FPDS.
About this IDV
The Joint Program Executive Office for Chemical and Biological Defense awarded an Other Transaction IDV to Dynavax Technologies Corporation on December 20, 2024, with a ceiling of $51,310,986 for the development of medical countermeasures for protection from pneumonic plague. Other Transactions operate outside the FAR and provide enhanced regulatory flexibility for innovative approaches to medical countermeasure development. Dynavax, a biopharmaceutical company headquartered in Emeryville, California, specializes in vaccine development and immune response therapies. The company brings extensive federal vaccine procurement and delivery experience, including multi-year supply contracts with the Centers for Disease Control and Prevention and the Department of Veterans Affairs, positioning it as an established provider of medical countermeasures across defense and public health agencies.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Funding Only Action | $8,091,904 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Funding Only Action | $4,200,433 | |
| Supplemental Agreement for work within scope | $12,000,000 | |
| Funding Only Action | $2,645,633 | |
| Funding Only Action | $2,002,980 | |
| Funding Only Action | $3,696,751 | |
| Funding Only Action | $3,759,000 | |
| Original award | $3,260,165 |
Show all 12
Quick answers
Who was awarded contract W911SR2590003?
W911SR2590003 was awarded to Dynavax Technologies Corporation by ACC Aberdeen Proving Ground (Army Contracting Command) on December 20, 2024.
How much is contract W911SR2590003 worth?
W911SR2590003's own ceiling is $51,310,986.
Which agency awarded contract W911SR2590003?
ACC Aberdeen Proving Ground (Army Contracting Command) awarded W911SR2590003, with funding from Joint PEO Chemical and Biological Defense (Acquisition Support Center).
Was contract W911SR2590003 competed?
The extent of competition for W911SR2590003 was competed.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV